2016-03-05T00:00:00.000-05:00
small molecule drugs,-0.637748
product candidates,0.476323
Director Donald J.,-0.217858
clinical stage biotechnology,-0.38639
consensus estimates,0.379449
stage biotechnology company,-0.38639
clinical trials,-0.726983
Co. Inc.,0.575897
quarterly earnings results,-0.262873
Balyasny Asset Management,0.519501
stock,0.231659
acute coronary syndrome,-0.70846
Fund Advisors LP,0.338487
InvestorPlace Broker Center,0.555736
Vitae Pharmaceuticals,-0.0415219
average price target,0.636057
multiple disease areas,-0.707978
outperform rating,0.425761
DAFNA Capital Management,0.482536
equities analysts,-0.431246
personal trading style,0.598412
Zacks Investment Research,0.365782
D. E. Shaw,0.575897
target price,0.471805
Capital Management LLC,0.482536
Pharmaceuticals Inc Daily,0.429096
buy rating,0.411239
Candriam Luxembourg S.C.A.,0.332581
equities research analysts,-0.218154
unmet medical needs,-0.625627
average price,0.114161
shares,0.198065
Alzheimer’s disease,-0.726983
concise daily summary,0.513846
stock broker,0.245696
consensus rating,0.636057
clinical trial,-0.427227
autoimmune disorders,-0.807634
new position,0.396856
